Market News & Trends
DSM Announces Biologics Development & Manufacturing Agreement
DSM Pharmaceutical Products recently announced it has signed a biologics contract manufacturing agreement with Paranta Biosciences Ltd of Melbourne, Australia. The contract covers the process…
Fuisz Pharma Announces Patented Film Formulations
Fuisz Pharma recently announced a patented film formulation for enhanced drug delivery performance. The seminal patent for this technology issued as United States Patent No.…
10/24/2012
Avantor & Rubicon to Collaborate on Next-Generation Functional Excipients Avantor Performance Materials recently announced it has signed a collaboration agreement with Rubicon Research Private…
Avantor & Rubicon to Collaborate on Next-Generation Functional Excipients
Avantor Performance Materials recently announced it has signed a collaboration agreement with Rubicon Research Private LTD of Mumbai, aimed at combining the Indian company's proprietary…
Catalent Announces Drug Delivery Institute
Catalent Pharma Solutions recently announced the launch of its Catalent Applied Drug Delivery Institute at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting…
EMD Millipore Announces Partnership With NIH Consortium
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, recently announced it has entered into an agreement with an academic consortium funded…
Foster Reports Increased Interest in Implantable Applications
Foster Corporation, a leader in custom medical polymers, recently reported increased interest in implantable medical device applications by polymer suppliers. While risk mitigation remains a…
Theravance & Merck Sign Major Cardiovascular Collaboration
Theravance, Inc.recently announced it has signed a collaboration agreement with Merck, known as MSD outside the United States and Canada, to discover, develop, and commercialize…
Unilife Develops Breakthrough Device Technologies
Unilife Corporationrecently announced the development of two new breakthrough platform technologies for targeted drug delivery that can enable and enhance patient outcomes for many acute…
10/16/2012
Catalent Licenses Innovative Technology Following a successful research collaboration, Catalent Pharma Solutions recently announced it has taken an exclusive license to innovative taste-masking technology developed…
Aptalis Sponsors AAPS Research Achievement Awards
Aptalis Pharmaceutical Technologies, formerly Eurand, focused on developing differentiated oral products utilizing its pharmaceutical technologies, recently announced its sponsorship of the American Association of Pharmaceutical…
Bend Research Receives US Patents for Technology to Enhance Bioavailability
Bend Research Inc. recently announced it has received two new US patents related to its pioneering efforts to improve the oral bioavailability of low-solubility drugs.…
Catalent Licenses Innovative Technology
Following a successful research collaboration, Catalent Pharma Solutions recently announced it has taken an exclusive license to innovative taste-masking technology developed by the New…
Frost & Sullivan Predicts Growth for Therapeutic Monoclonal Antibodies
Efficient resource to therapy of complex disorders with lesser side-effects has accelerated growth of monoclonal antibodies-based therapeutics against conventional chemical drugs. However, high developmental costs…
Future of Pharmaceutical R&D Requires Innovative Dosage Formulations
A survey of 500 pharmaceutical industry influencers reveals that four out of five surveyed (82%) believe innovative dosage form technologies are required to meet the…
Pharmacyclics Inks Agreement With Novo Nordisk
Pharmacyclics Inc. recently announced it has signed an agreement with Novo Nordisk A/S giving the Danish insulin producer rights to certain uses of its Factor…
10/10/2012
Cleveland BioLabs & Incuron Announce Orphan Drug Status Cleveland BioLabs, Inc. and Incuron, LLC, a joint venture between the company and Bioprocess Capital Ventures, recently…
4P Therapeutics Announces Major Development Partnership
4P Therapeutics, a drug delivery company with expertise in novel drug delivery technologies, recently announced a partnership with Medicure Inc. for the development of a…
Bend Research & Dow Chemical to Develop Drug-Solubility Solutions & New Polymers
Bend Research Inc. and The Dow Chemical Company have formed an exclusive collaboration to provide science-based spray-dried dispersion (SDD) solutions and select enabling new polymers…
Catalent Strikes Agreement With Vivus
Catalent Pharma Solutions recently announced it has entered into a Supply Agreement with VIVUS, Inc. to supply Qsymia capsules, a proprietary combination phentermine and extended-release…
